Analystreport

Clovis Oncology (NASDAQ: CLVS) had its "buy" rating re-affirmed by analysts at G.Research, Llc.

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report